. | Study 1 (intraduodenal glucose at 2 kcal/min) . | Study 2 (intraduodenal glucose at 3 kcal/min) . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Female (n = 9) . | Male (n = 20) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | Female (n = 10) . | Male (n = 26) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | |
Age (years) | 25.0 (21.5, 26.0) | 21.0 (19.0, 27.8) | 0.19 | — | — | 25.0 (21.8, 27.0) | 23.5 (21.0, 28.0) | 0.50 | — | — |
Weight (kg) | 57.1 ± 2.9 | 72.9 ± 4.1 | 0.001 | — | — | 62.3 (54.3, 92.6) | 73.8 (67.1, 90.1) | 0.09 | — | — |
BMI (kg/m2) | 21.5 (20.1, 23.7) | 22.7 (21.8, 24.2) | 0.28 | — | — | 23.2 (20.2, 31.5) | 24.3 (22.7, 28.3) | 0.51 | — | — |
Fasting blood glucose (mmol/L) | 5.3 ± 0.2 | 5.2 ± 0.4 | 0.95 | 0.32 | 0.47 | 5.4 ± 0.2 | 5.4 ± 0.1 | 0.83 | 0.93 | 0.81 |
Glucose iAUC0-60min (mmol/L*min) | 135.7 ± 13.9 | 144.2 ± 10.4 | 0.75 | 0.35 | 0.44 | 99.8 ± 11.7 | 110.4 ± 8.0 | 0.47 | 0.59 | 0.51 |
Fasting plasma insulin (mU/L) | 2.9 ± 0.4 | 2.4 ± 0.3 | 0.45 | 0.33 | 0.48 | 4.7 (2.4, 6.8) | 5.0 (2.2, 13.3) | 0.71 | 0.18 | 0.51 |
Insulin iAUC0-60min (mU/L*min) | 1631.3 (1278.4, 2137.9) | 834.3 (66.24, 1114.1) | 0.005 | 0.011 | 0.025 | 1738.9 (1345.9, 4772.1) | 1897.1 (1093.1, 4252.5) | 0.99 | 0.86 | 0.85 |
Fasting plasma GIP (pmol/L) | 10.9 ± 1.7 | 10.3 ± 1.4 | 0.81 | 0.61 | 0.62 | 11.2 (7.5, 16.5) | 11.5 (6.6, 14.5) | 0.79 | 0.96 | 0.95 |
GIP iAUC0-60min (pmol/L*min) | 1283.9 ± 121.7 | 1352.1 ± 105.3 | 0.96 | 0.82 | 0.78 | 1006.2 ± 131.6 | 1030.3 ± 68.6 | 0.86 | 0.74 | 0.83 |
Fasting plasma GLP-1 (pmol/L) | 19.5 ± 2.0 | 23.0 ± 1.5 | 0.17 | 0.08 | 0.07 | 16.7 (14.6, 19.6) | 15.7 (10.3, 20.7) | 0.46 | 0.61 | 0.63 |
GLP-1 iAUC0-60min (pmol/L*min) | 524.8 ± 104.6 | 264.3 ± 57.2 | 0.025 | 0.016 | 0.039 | 640.5 (280.2, 1002.4) | 205.5 (87.8, 274.3) | 0.011 | 0.012 | 0.005 |
. | Study 1 (intraduodenal glucose at 2 kcal/min) . | Study 2 (intraduodenal glucose at 3 kcal/min) . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Female (n = 9) . | Male (n = 20) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | Female (n = 10) . | Male (n = 26) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | |
Age (years) | 25.0 (21.5, 26.0) | 21.0 (19.0, 27.8) | 0.19 | — | — | 25.0 (21.8, 27.0) | 23.5 (21.0, 28.0) | 0.50 | — | — |
Weight (kg) | 57.1 ± 2.9 | 72.9 ± 4.1 | 0.001 | — | — | 62.3 (54.3, 92.6) | 73.8 (67.1, 90.1) | 0.09 | — | — |
BMI (kg/m2) | 21.5 (20.1, 23.7) | 22.7 (21.8, 24.2) | 0.28 | — | — | 23.2 (20.2, 31.5) | 24.3 (22.7, 28.3) | 0.51 | — | — |
Fasting blood glucose (mmol/L) | 5.3 ± 0.2 | 5.2 ± 0.4 | 0.95 | 0.32 | 0.47 | 5.4 ± 0.2 | 5.4 ± 0.1 | 0.83 | 0.93 | 0.81 |
Glucose iAUC0-60min (mmol/L*min) | 135.7 ± 13.9 | 144.2 ± 10.4 | 0.75 | 0.35 | 0.44 | 99.8 ± 11.7 | 110.4 ± 8.0 | 0.47 | 0.59 | 0.51 |
Fasting plasma insulin (mU/L) | 2.9 ± 0.4 | 2.4 ± 0.3 | 0.45 | 0.33 | 0.48 | 4.7 (2.4, 6.8) | 5.0 (2.2, 13.3) | 0.71 | 0.18 | 0.51 |
Insulin iAUC0-60min (mU/L*min) | 1631.3 (1278.4, 2137.9) | 834.3 (66.24, 1114.1) | 0.005 | 0.011 | 0.025 | 1738.9 (1345.9, 4772.1) | 1897.1 (1093.1, 4252.5) | 0.99 | 0.86 | 0.85 |
Fasting plasma GIP (pmol/L) | 10.9 ± 1.7 | 10.3 ± 1.4 | 0.81 | 0.61 | 0.62 | 11.2 (7.5, 16.5) | 11.5 (6.6, 14.5) | 0.79 | 0.96 | 0.95 |
GIP iAUC0-60min (pmol/L*min) | 1283.9 ± 121.7 | 1352.1 ± 105.3 | 0.96 | 0.82 | 0.78 | 1006.2 ± 131.6 | 1030.3 ± 68.6 | 0.86 | 0.74 | 0.83 |
Fasting plasma GLP-1 (pmol/L) | 19.5 ± 2.0 | 23.0 ± 1.5 | 0.17 | 0.08 | 0.07 | 16.7 (14.6, 19.6) | 15.7 (10.3, 20.7) | 0.46 | 0.61 | 0.63 |
GLP-1 iAUC0-60min (pmol/L*min) | 524.8 ± 104.6 | 264.3 ± 57.2 | 0.025 | 0.016 | 0.039 | 640.5 (280.2, 1002.4) | 205.5 (87.8, 274.3) | 0.011 | 0.012 | 0.005 |
Abbreviations: BMI, body mass index; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; iAUC0-60min, incremental area under the curve between t = 0-60 minutes.
Normally distributed data are expressed as means ± SEM, while data that are not normally distributed are expressed as median (25% and 75% interquartile range). The bold text used in the table is to emphasis the statistic significance (P < 0.05).
. | Study 1 (intraduodenal glucose at 2 kcal/min) . | Study 2 (intraduodenal glucose at 3 kcal/min) . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Female (n = 9) . | Male (n = 20) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | Female (n = 10) . | Male (n = 26) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | |
Age (years) | 25.0 (21.5, 26.0) | 21.0 (19.0, 27.8) | 0.19 | — | — | 25.0 (21.8, 27.0) | 23.5 (21.0, 28.0) | 0.50 | — | — |
Weight (kg) | 57.1 ± 2.9 | 72.9 ± 4.1 | 0.001 | — | — | 62.3 (54.3, 92.6) | 73.8 (67.1, 90.1) | 0.09 | — | — |
BMI (kg/m2) | 21.5 (20.1, 23.7) | 22.7 (21.8, 24.2) | 0.28 | — | — | 23.2 (20.2, 31.5) | 24.3 (22.7, 28.3) | 0.51 | — | — |
Fasting blood glucose (mmol/L) | 5.3 ± 0.2 | 5.2 ± 0.4 | 0.95 | 0.32 | 0.47 | 5.4 ± 0.2 | 5.4 ± 0.1 | 0.83 | 0.93 | 0.81 |
Glucose iAUC0-60min (mmol/L*min) | 135.7 ± 13.9 | 144.2 ± 10.4 | 0.75 | 0.35 | 0.44 | 99.8 ± 11.7 | 110.4 ± 8.0 | 0.47 | 0.59 | 0.51 |
Fasting plasma insulin (mU/L) | 2.9 ± 0.4 | 2.4 ± 0.3 | 0.45 | 0.33 | 0.48 | 4.7 (2.4, 6.8) | 5.0 (2.2, 13.3) | 0.71 | 0.18 | 0.51 |
Insulin iAUC0-60min (mU/L*min) | 1631.3 (1278.4, 2137.9) | 834.3 (66.24, 1114.1) | 0.005 | 0.011 | 0.025 | 1738.9 (1345.9, 4772.1) | 1897.1 (1093.1, 4252.5) | 0.99 | 0.86 | 0.85 |
Fasting plasma GIP (pmol/L) | 10.9 ± 1.7 | 10.3 ± 1.4 | 0.81 | 0.61 | 0.62 | 11.2 (7.5, 16.5) | 11.5 (6.6, 14.5) | 0.79 | 0.96 | 0.95 |
GIP iAUC0-60min (pmol/L*min) | 1283.9 ± 121.7 | 1352.1 ± 105.3 | 0.96 | 0.82 | 0.78 | 1006.2 ± 131.6 | 1030.3 ± 68.6 | 0.86 | 0.74 | 0.83 |
Fasting plasma GLP-1 (pmol/L) | 19.5 ± 2.0 | 23.0 ± 1.5 | 0.17 | 0.08 | 0.07 | 16.7 (14.6, 19.6) | 15.7 (10.3, 20.7) | 0.46 | 0.61 | 0.63 |
GLP-1 iAUC0-60min (pmol/L*min) | 524.8 ± 104.6 | 264.3 ± 57.2 | 0.025 | 0.016 | 0.039 | 640.5 (280.2, 1002.4) | 205.5 (87.8, 274.3) | 0.011 | 0.012 | 0.005 |
. | Study 1 (intraduodenal glucose at 2 kcal/min) . | Study 2 (intraduodenal glucose at 3 kcal/min) . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Female (n = 9) . | Male (n = 20) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | Female (n = 10) . | Male (n = 26) . | P (no correction) . | P (corrected for body weight) . | P (corrected for BMI) . | |
Age (years) | 25.0 (21.5, 26.0) | 21.0 (19.0, 27.8) | 0.19 | — | — | 25.0 (21.8, 27.0) | 23.5 (21.0, 28.0) | 0.50 | — | — |
Weight (kg) | 57.1 ± 2.9 | 72.9 ± 4.1 | 0.001 | — | — | 62.3 (54.3, 92.6) | 73.8 (67.1, 90.1) | 0.09 | — | — |
BMI (kg/m2) | 21.5 (20.1, 23.7) | 22.7 (21.8, 24.2) | 0.28 | — | — | 23.2 (20.2, 31.5) | 24.3 (22.7, 28.3) | 0.51 | — | — |
Fasting blood glucose (mmol/L) | 5.3 ± 0.2 | 5.2 ± 0.4 | 0.95 | 0.32 | 0.47 | 5.4 ± 0.2 | 5.4 ± 0.1 | 0.83 | 0.93 | 0.81 |
Glucose iAUC0-60min (mmol/L*min) | 135.7 ± 13.9 | 144.2 ± 10.4 | 0.75 | 0.35 | 0.44 | 99.8 ± 11.7 | 110.4 ± 8.0 | 0.47 | 0.59 | 0.51 |
Fasting plasma insulin (mU/L) | 2.9 ± 0.4 | 2.4 ± 0.3 | 0.45 | 0.33 | 0.48 | 4.7 (2.4, 6.8) | 5.0 (2.2, 13.3) | 0.71 | 0.18 | 0.51 |
Insulin iAUC0-60min (mU/L*min) | 1631.3 (1278.4, 2137.9) | 834.3 (66.24, 1114.1) | 0.005 | 0.011 | 0.025 | 1738.9 (1345.9, 4772.1) | 1897.1 (1093.1, 4252.5) | 0.99 | 0.86 | 0.85 |
Fasting plasma GIP (pmol/L) | 10.9 ± 1.7 | 10.3 ± 1.4 | 0.81 | 0.61 | 0.62 | 11.2 (7.5, 16.5) | 11.5 (6.6, 14.5) | 0.79 | 0.96 | 0.95 |
GIP iAUC0-60min (pmol/L*min) | 1283.9 ± 121.7 | 1352.1 ± 105.3 | 0.96 | 0.82 | 0.78 | 1006.2 ± 131.6 | 1030.3 ± 68.6 | 0.86 | 0.74 | 0.83 |
Fasting plasma GLP-1 (pmol/L) | 19.5 ± 2.0 | 23.0 ± 1.5 | 0.17 | 0.08 | 0.07 | 16.7 (14.6, 19.6) | 15.7 (10.3, 20.7) | 0.46 | 0.61 | 0.63 |
GLP-1 iAUC0-60min (pmol/L*min) | 524.8 ± 104.6 | 264.3 ± 57.2 | 0.025 | 0.016 | 0.039 | 640.5 (280.2, 1002.4) | 205.5 (87.8, 274.3) | 0.011 | 0.012 | 0.005 |
Abbreviations: BMI, body mass index; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; iAUC0-60min, incremental area under the curve between t = 0-60 minutes.
Normally distributed data are expressed as means ± SEM, while data that are not normally distributed are expressed as median (25% and 75% interquartile range). The bold text used in the table is to emphasis the statistic significance (P < 0.05).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.